Prateek Agarwal, MD, MBA (@teeksagarwal) header
Prateek Agarwal, MD, MBA (@teeksagarwal) profile picture

Prateek Agarwal, MD, MBA

@teeksagarwal

PGY-7 and enfolded endovascular fellow @PittNeurosurg. MD/MBA @PennMedicine and @Wharton. @Harvard @LvilleSchool alumnus.

 Philadelphia, PA
linkedin.com/in/pagarwal13
Joined October 2017
  • Tweets822
  • Following664
  • Followers1.2K
14Media
Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)Photo by Prateek Agarwal, MD, MBA (@teeksagarwal)
Excited to share our important findings published in @JAMASurgery demonstrating that use of beta-lactam abx ppx is associated with lower SSI rate - huge thank you to @Rohit_PremKumar and grateful for mentorship from @DrRFriedlander @NitinAgarwalMD ja.ma/4nYhawg
Image from Prateek Agarwal, MD, MBA (@teeksagarwal)
2
10
1
33
3,107
Prateek Agarwal, MD, MBA retweeted
SCOLI (@SCOLIorg) profile picture
SCOLI
@SCOLIorgNov 3
Book signing is underway now at #CNS2026! Come stop by and say hello! @NitinAgarwalMD @CNS_Update #2026CNS
Image from SCOLI (@SCOLIorg)
Image from SCOLI (@SCOLIorg)
Image from SCOLI (@SCOLIorg)
Image from SCOLI (@SCOLIorg)
4
1
13
1,604
Prateek Agarwal, MD, MBA retweeted
SCOLI (@SCOLIorg) profile picture
SCOLI
@SCOLIorgNov 3
Great crowd at @NitinAgarwalMD’s book signing!
3
9
352
Prateek Agarwal, MD, MBA retweeted
NEJM (@NEJM) profile picture
NEJM
@NEJMOct 25
Original Article: Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion (MILD-MT trial) nej.md/4hWstFc #Neurology #EmergencyMedicine
Bar graph showing the percentage of patients on the Modified Rankin Scale, comparing "EVT plus Medical Management" (N=144) and "Medical Management Alone" (N=156). Scores range from 0 to 6. The distribution is labeled with percentages and number of patients for each category.

ALT Bar graph showing the percentage of patients on the Modified Rankin Scale, comparing "EVT plus Medical Management" (N=144) and "Medical Management Alone" (N=156). Scores range from 0 to 6. The distribution is labeled with percentages and number of patients for each category.

A forest plot comparing EVT plus Medical Management to Medical Management Alone for various subgroups, showing adjusted odds ratios and confidence intervals. Subgroups include age, sex, time from onset to randomization, site of occlusion, cause of stroke, baseline NIHSS score, intravenous thrombolysis, and perfusion-mismatch volume.

ALT A forest plot comparing EVT plus Medical Management to Medical Management Alone for various subgroups, showing adjusted odds ratios and confidence intervals. Subgroups include age, sex, time from onset to randomization, site of occlusion, cause of stroke, baseline NIHSS score, intravenous thrombolysis, and perfusion-mismatch volume.

1
39
2
119
22,168
Prateek Agarwal, MD, MBA retweeted
NEJM (@NEJM) profile picture
NEJM
@NEJMOct 25
Original Article: Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke (LATE-MT trial) nej.md/3VWTUpV Editorial: Expanding the Evidence and Indications for Thrombectomy in Ischemic Stroke nej.md/4hWsxVs #Neurology #Surgery
Bar graph showing the percentage of patients on the Modified Rankin Scale, comparing "Intervention" (N=167) and "Control" (N=167). Scores range from 0 to 6. The distribution is labeled with percentages for each category.

ALT Bar graph showing the percentage of patients on the Modified Rankin Scale, comparing "Intervention" (N=167) and "Control" (N=167). Scores range from 0 to 6. The distribution is labeled with percentages for each category.

This image shows a forest plot comparing the intervention and control groups. Subgroups include age, time from onset to randomization, and type of stroke. Hazard ratios with 95% confidence intervals are displayed, indicating whether the intervention or control is better for a primary outcome.

ALT This image shows a forest plot comparing the intervention and control groups. Subgroups include age, time from onset to randomization, and type of stroke. Hazard ratios with 95% confidence intervals are displayed, indicating whether the intervention or control is better for a primary outcome.

2
47
8
157
33,900
Prateek Agarwal, MD, MBA retweeted
Justin R. Mascitelli, MD, FAANS (@jmascite) profile picture
Justin R. Mascitelli, MD, FAANS@jmasciteOct 10
Always the best vascular course of the year! Thank you @NREFORG ! @BrianHoward_MD @DrAndrewGrande @DrMichaelJLang @JOsbunMDxCV @JAGrossbergMD @bainmd @OUAVMdoc @KhanNickalus @AliAlawiehmdphd @mtlawton @_AdnanSiddiqui @AdamArthurMD @cvsection @chriskellnerMD
Image from Justin R. Mascitelli, MD, FAANS (@jmascite)
1
13
2
33
5,013
Prateek Agarwal, MD, MBA retweeted
Pitt Neurosurgery (@PittNeurosurg) profile picture
Pitt Neurosurgery
@PittNeurosurgJun 22
Congratulations to our four graduating residents! The University of Pittsburgh Department of Neurological Surgery is proud to recognize Dr. Ali Alattar, Dr. Hansen Deng, Dr. Joseph Hudson, and Dr. Andrew Legarreta on the successful completion of their residency training. Over the course of their training, each has demonstrated exceptional clinical skill and compassion in the care of every patient. Their contributions to our department and to the patients they served reflect the highest standards of the profession. As they begin the next stage of their careers, they carry with them the lasting respect and gratitude of our faculty and staff, and will always remain part of the Pitt Neurosurgery family. We extend our sincere congratulations and best wishes for continued success. @js_hudson @adlegarreta @pascalzinn
Image from Pitt Neurosurgery (@PittNeurosurg)
Image from Pitt Neurosurgery (@PittNeurosurg)
Image from Pitt Neurosurgery (@PittNeurosurg)
Image from Pitt Neurosurgery (@PittNeurosurg)
1
9
1
67
8,744
Prateek Agarwal, MD, MBA retweeted
NEJM (@NEJM) profile picture
NEJM
@NEJMMay 13
Among patients with stroke due to medium-vessel occlusion, thrombectomy led to functional independence at 90 days (in 58.6% of patients, vs. 46.6% with medical management) but also to a higher risk of intracranial hemorrhage. Full ORIENTAL-MeVO trial results: nej.md/42z7dNj Editorial: Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population nej.md/4d9ALY4
This is an image from the Original Article "Endovascular Treatment of Medium-Vessel-Occlusion Strokes" published in the New England Journal of Medicine on May 14, 2026. The trial name, ORIENTAL-MeVO, has been added to the title. Below the title, a chart is shown comparing the Modified Rankin Scale scores of the control and endovascular thrombectomy groups, illustrating the distribution of functional outcomes at 90 days. The chart uses percentages to display outcomes for scores ranging from 0 to 6.

ALT This is an image from the Original Article "Endovascular Treatment of Medium-Vessel-Occlusion Strokes" published in the New England Journal of Medicine on May 14, 2026. The trial name, ORIENTAL-MeVO, has been added to the title. Below the title, a chart is shown comparing the Modified Rankin Scale scores of the control and endovascular thrombectomy groups, illustrating the distribution of functional outcomes at 90 days. The chart uses percentages to display outcomes for scores ranging from 0 to 6.

1
73
2
157
23,670
Prateek Agarwal, MD, MBA retweeted
Pitt Neurosurgery (@PittNeurosurg) profile picture
Pitt Neurosurgery
@PittNeurosurgMay 2
Congratulations Dr. Jacobs!
UCSF Neurosurgery (@NeurosurgUCSF) profile pictureUCSF Neurosurgery@NeurosurgUCSFMay 2
.@UCSFHospitals spine neurosurgeon Praveen Mummaneni, MD, kicked off Plenary II at #AANS2026 by presenting the Veena D. Mummaneni Award to @PittNeurosurg’s Rachel Jabcobs, MD. Congrats to Dr. Jacobs for developing a risk grading scheme for middle meningeal artery embolization!
Praveen Mummanei, MD, presents the award to Rachel Jacobs, MD.

ALT Praveen Mummanei, MD, presents the award to Rachel Jacobs, MD.

Presentation slide with a graphic announcing Praveen Mummaneni, MD, MBA, FAANS, with the role of presenting the Veena D. Mummaneni Award.

ALT Presentation slide with a graphic announcing Praveen Mummaneni, MD, MBA, FAANS, with the role of presenting the Veena D. Mummaneni Award.

Praveen Mummaneni, MD, at the podium announcing the award, which was established in honor of Veena Mummaneni and is given to the woman resident or fellow with the top scoring abstract at AANS.

ALT Praveen Mummaneni, MD, at the podium announcing the award, which was established in honor of Veena Mummaneni and is given to the woman resident or fellow with the top scoring abstract at AANS.

4
20
1,878
Prateek Agarwal, MD, MBA retweeted
CV Section (@cvsection) profile picture
CV Section
@cvsectionMay 1
AANS 2026 kickoff: CV Section Executive Committee meeting—plus our now-traditional resident meet & greet connecting cerebrovascular leaders with the next generation. #neurosurgery #cerebrovascular
Image from CV Section (@cvsection)
6
1
22
1,595
Prateek Agarwal, MD, MBA retweeted
Pitt Neurosurgery (@PittNeurosurg) profile picture
Pitt Neurosurgery
@PittNeurosurgMar 20
The University of Pittsburgh Dept. of Neurological Surgery is thrilled to announce our 2026 residency match class. These five exceptional individuals represent the next generation of neurosurgical leaders, and their passion for advancing the field and delivering outstanding patient care embodies the mission of our program. Welcome to Pitt Neurosurgery!
Image from Pitt Neurosurgery (@PittNeurosurg)
2
20
3
157
21,244
Prateek Agarwal, MD, MBA retweeted
Ashwin R. Reddy, MD (@ashwinrreddy) profile picture
Ashwin R. Reddy, MD@ashwinrreddyMar 17
I matched into otolaryngology–head & neck surgery!! Grateful for the mentors, family, and experiences that got me here — excited for what’s ahead #ENT #OtoMatch #Match2026
Image from Ashwin R. Reddy, MD (@ashwinrreddy)
13
18
1
462
8,888
Prateek Agarwal, MD, MBA retweeted
Jason Davies, MD,PhD (@JMDaviesMDPhD) profile picture
Jason Davies, MD,PhD@JMDaviesMDPhDFeb 5
#EMBOLISE2 Observation cohort showed ~2fold reduction in composite primary endpoint of surgical rescue, poor clinical outcome or clinical deterioration. NNT 9 #ISC26
Image from Jason Davies, MD,PhD (@JMDaviesMDPhD)
3
14
30
2,519
Prateek Agarwal, MD, MBA retweeted
Jason Davies, MD,PhD (@JMDaviesMDPhD) profile picture
Jason Davies, MD,PhD@JMDaviesMDPhDFeb 5
#EMBOLISE2 Observation cohort showed that we need to keep our SDH patients on AC/AP. High baseline rates of comorbidity mean they suffer if we stop their meds. #ISC26
Image from Jason Davies, MD,PhD (@JMDaviesMDPhD)
Image from Jason Davies, MD,PhD (@JMDaviesMDPhD)
2
11
1
27
5,319
Prateek Agarwal, MD, MBA retweeted
NEJM (@NEJM) profile picture
NEJM
@NEJM6 Dec 2025
Although ventricular enlargement is a key feature of idiopathic normal-pressure hydrocephalus (iNPH), this finding alone is nonspecific, occurring in many conditions, including brain volume loss with aging. The ventriculomegaly of idiopathic normal-pressure hydrocephalus is often described as “out of proportion to brain atrophy,” which is a subjective assessment. Read the full review: nej.md/4pxWVad
Figures showing imaging features of idiopathic normal-pressure hydrocephalus, programmable cerebrospinal fluid shunt surgery, and surgical risks.

ALT Figures showing imaging features of idiopathic normal-pressure hydrocephalus, programmable cerebrospinal fluid shunt surgery, and surgical risks.

3
67
2
286
56,122
Landmark results!
NEJM (@NEJM) profile pictureNEJM
@NEJM21 Nov 2025
Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: nej.md/3LK9kst Editorial: Managing Asymptomatic Carotid Stenosis nej.md/482XjG1 @svinsociety
The Society of Vascular and Interventional Neurology 2025 Annual Meeting Original Article | NOV 21, 2025 | NEJM.org Medical Management and Revascularization for Asymptomatic Carotid Stenosis Figure 2A. Primary-Outcome Analysis. The NEJM signature sits at the bottom.

ALT The Society of Vascular and Interventional Neurology 2025 Annual Meeting Original Article | NOV 21, 2025 | NEJM.org Medical Management and Revascularization for Asymptomatic Carotid Stenosis Figure 2A. Primary-Outcome Analysis. The NEJM signature sits at the bottom.

6
824
Prateek Agarwal, MD, MBA retweeted
JAMA Neurology (@JAMANeuro) profile picture
JAMA Neurology@JAMANeuro13 Oct 2025
General anesthesia improved 90-day disability outcomes and increased the rate of successful reperfusion compared with moderate sedation in patients undergoing endovascular thrombectomy for acute ischemic stroke. ja.ma/48WkFiw
Image from JAMA Neurology (@JAMANeuro)
47
3
110
13,892
@UPMC @UPMCnews @PittNeurosurg @Pitt_NSIG
2
5
286
@PittHealthSci @UPMCPhysicianEd
1
5
269
Excited to share our important findings! @Rohit_PremKumar
JAMA Surgery (@JAMASurgery) profile pictureJAMA Surgery@JAMASurgery1 Oct 2025
Across surgical specialties, β-lactam antibiotics for surgical prophylaxis was associated with lower surgical site infection incidence compared with non–β-lactams. ja.ma/4nYhawg
Image from JAMA Surgery (@JAMASurgery)
1
1
20
2,155
Load more